Key Segmentation
By Device Type
- Point-of-Care Devices
- Benchtop Laboratory Analyzers
By Technology
- HPLC
- Immunoassay
By End-User
- Hospitals
- Diagnostic and Reference Laboratories
By Patient Age Group
- Adults
- Geriatric
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- ASEAN Countries
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Available Customization
With the given market data SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g. Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
The HbA1c Testing Devices Market is expected to grow at a CAGR of 8.42% from 2026 to 2035.
The HbA1c Testing Devices Market was valued at USD 2.33 Billion in 2025.
Rising diabetes prevalence combined with the decentralization of diagnostics toward near-patient settings is the major growth factor.
The Point-of-Care Devices segment held approximately 76.53% share in 2025 and was also the fastest-growing device type segment.
Get in Touch
